S.A. Wring et al.: Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis. In: Antimicrobial Agents and Chemotherapy. 24. März 2017, doi:10.1128/AAC.02068-16.
E. Kuhnert et al.: Enfumafungin synthase represents a novel lineage of fungal triterpene cyclases. In: Environmental Microbiology. 2018, doi:10.1111/1462-2920.14333, PMC 6237087 (freier Volltext).